Brucein D augments the chemosensitivity of gemcitabine in pancreatic cancer via inhibiting the Nrf2 pathway

Juan Zhang(Fujian Medical University), Zhi‐Xiu Lin(Chinese University of Hong Kong)
Journal of Experimental & Clinical Cancer Research
March 10, 2022
Cited by 28


Related Papers